Pituitary Adenomas: Evaluation and Management. Fawn M. Wolf, MD 10/27/17

Similar documents
Functional Pituitary Adenomas. Fawn M. Wolf, MD 2/2/2018

Pituitary Tumors and Incidentalomas. Bijan Ahrari, MD, FACE, ECNU Palm Medical Group

PITUITARY: JUST THE BASICS PART 2 THE PATIENT

Initials:.. Number of patient in the registry:... Date of visit:.. Gender (genetic): female / male

Pituitary for the General Practitioner. Marilyn Lee Consultant physician and endocrinologist

JACK L. SNITZER, DO INTERNAL MEDICINE BOARD REVIEW COURSE 2018 PITUITARY

Pituitary Disorders Suranut Charoensri, MD

Introduction to Endocrinology. Hypothalamic and Pituitary diseases Prolactinoma + Acromegaly

in Primary Care (Part 2) Jonathan R. Anolik, MD, FACP, FACE Lewis Katz School of Medicine at Temple University

Imaging pituitary gland tumors

HYPOTHALAMO PITUITARY GONADAL AXIS

Mechanism of hyperprolactinemia

Diseases of pituitary gland

GLMS CME- Cell Group 5 10 April Greenlane Medical Specialists Pui-Ling Chan Endocrinologist

(3) Pituitary tumours

UW MEDICINE PATIENT EDUCATION. Acromegaly Symptoms and treatments. What is acromegaly? DRAFT. What are the symptoms? How is it diagnosed?

Endocrine part two. Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy

Somatotroph Pituitary Adenomas (Acromegaly) The Diagnostic Pathway (11-2K-234)

Hypothalamus & Pituitary Gland

Endocrine Testing. Alice Y.Y. Cheng, MD, FRCP October 14, 2015

What we will cover. Evaluation of the Child with Suspected Pituitary Disease. ituitary

Professor Ian Holdaway. Endocrinologist Auckland District Health Board

Neuroendocrine Disorders in Women

Take Home Messages in Endocrinology

Pathology of pituitary gland. By: Shifaa Qa qa

Clinical presentations of endocrine diseases

Pituitary Gland Disorders

Prolactin-Secreting Pituitary Adenomas (Prolactinomas) The Diagnostic Pathway (11-2K-234)

Hormones by location

Pituitary gland diseases

Medical and Rehabilitation Innovations Neuroendocrine Screening and Hormone Replacement Therapy in Trauma Related Acquired Brain Injury

Endocrine system overview

Cortisol levels. Naturally produced by the adrenal Cortisol

Case Report Rapid Pituitary Apoplexy Regression: What Is the Time Course of Clot Resolution?

THE ANTERIOR PITUITARY. Embryology cont. Embryology of the pituitary BY MISPA ZUH HS09A179. Embryology cont. THE PITUIYARY GLAND Anatomy:

Endocrinological Outcome Among Treated Craniopharyngioma Patients

Reproductive Health and Pituitary Disease

Pituitary Stalk Interruption Syndrome. Leena Shahla, MD, PGY5 Endocrinology, Diabetes and Metabolism Fellowship University of Massachusetts

Disclosures. BMS, Ferring research grant funding NovoNordisk scientific advisory board Chiasma clinical trial investigator

Management of incidental pituitary microadenomas: a cost-effectiveness analysis King J T, Justice A C, Aron D C

Overview of Reproductive Endocrinology

Pharmacology of Hypothalamic Hormones

Hyperprolactinemia: N hidshi i MD. Nahid Shirazian MD. Internist, Endocrinologist

Kingdom of Bahrain Arabian Gulf University College of Medicine and Medical Sciences. Endocrinology. (Review) Year 5 Internal Medicine

47 Year-Old Female with Headache. Olesya Krivospitskaya, MD Second year endocrinology fellow

Chapter 12 Endocrine System (export).notebook. February 27, Mar 17 2:59 PM. Mar 17 3:09 PM. Mar 17 3:05 PM. Mar 17 3:03 PM.

Hyperprolactinemia in A 15-Year-Old Girl with Primary Amenorrhea

Ch 8: Endocrine Physiology

Human Biochemistry. Hormones

Pituitary gland Pituitary fossa Mass: 5 gms DIMENSIONS 7mm (Ht) 9mm (AP) 11m(transverse) originates from Rathke s pouch and infundibulum

Growth Hormone, Somatostatin, and Prolactin 1 & 2 Mohammed Y. Kalimi, Ph.D.

Indications for Surgical Removal of Adrenal Glands

Evaluation and Management of Pituitary Failure. Dr S. Ali Imran MBBS, FRCP (Edin), FRCPC Professor of Medicine Dalhousie University, Halifax, NS

Imaging The Turkish Saddle. Russell Goodman, HMS III Dr. Gillian Lieberman

Pituitary adenomas and menopause

Challenging Pituitary Cases. Laurence Katznelson, MD Professor of Medicine and Neurosurgery Stanford University School of Medicine

Pituitary Disease Resident Tutorial 2017

Checking the Right Box at the Right Age: the Art of Pediatric Endocrine Testing

Urgent and Emergent Pituitary Conditions

Robert Wadlow and his father

High and Low GH: an update of diagnosis and management of GH disorders

Endocrine Pharmacology

Endocrine part one. Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy

14 Girl with Cushing s Disease: An Update. Kristen Dillard, MD Endorama October 17, 2013

Non-Functioning Tumours and Pituitary Hormone Testing. Miguel Debono Consultant in Endocrinology

Secondary amenorrhoea Dr.ASMAA AL SANJARY

Pituitary, Parathyroid Pheochromocytomas & Paragangliomas: The 4 Ps of NETs

Sharon maslovitz Lis Maternity Hospital

Metoclopramide Domperidone. HYPER- PROLACTINAEMIA: the true and the false problems

Peri-op Pituitary / Diabetes Insipidus/ Apoplexy Dr. Stan Van Uum, MD, PhD, FRCPC

62-year-old woman with severe headache. Celeste Thomas November 1, 2012

John Sutton, DO, FACOI, FACE, CCD. Carson Tahoe Endocrinology Carson City, NV KCOM Class of 1989

The most current assessment of this problem can be found in the Apex note dated

Spontaneous remission of acromegaly and Cushing s disease following pituitary apoplexy: Two case reports

Endocrine system release hormones to regulates physiological process e.g growth, reproduction, metabolism, mentrual cycle, development of secondary

Endocrine Topic Review. Sethanant Sethakarun, MD

NANOS Patient Brochure

Endocrine System. Overview Hormones Endocrine Organs

4.04 Understand the Functions and Disorders of the ENDOCRINE SYSTEM Understand the functions and disorders of the endocrine system

A Combined Case of Macroprolactinoma, Growth Hormone Excess and Graves' Disease

Endocrine System. Overview Hormones Endocrine Organs

Stelios Mantis, MD DuPage Medical Group Pediatric Endocrinology

panhypopituitarism Pattawan Wongwijitsook Maharat Nakhon Ratchasima hospital 17 Nov 2013

33-Year-Old Female With Amenorrhea DISHA KUMAR NARANG, MD PITUITARY ENDORAMA DECEMBER 11, 2014

ENDOCRINE SYSTEM 29 MAY 2013

Treating a Growing Problem: A Closer Look at Acromegaly. Lisa Nachtigall, MD (Moderator) Nicholas Tritos, MD, DSc Brooke Swearingen, MD

Endocrine System. Overview Hormones Endocrine Organs

Case Report A Rare Corticotroph-Secreting Tumor with Coexisting Prolactin and Growth Hormone Staining Cells

Scrub In. TSH is secreted by the pituitary and acts on the: Parathormone tends to increase the concentration of:

NOTES 11.5: ENDOCRINE SYSTEM. Pages

PATIENT INFORMATION HYPOPITUITARISM YOUR QUESTIONS ANSWERED

Acromegaly: a challenging condition to diagnose and manage. C. L. Chik, MD, PhD, FRCPC University of Alberta, Edmonton

CUSHING SYNDROME Dr. Muhammad Sarfraz

Pathophysiology of Pituitary Gland Disorders. PHCL 415 Hadeel Alkofide May 2010

Female Reproductive Endocrinology

Pituitary apoplexy 台北榮總內分泌新陳代謝科主治醫師林怡君

Pituitary Disorders Pearls

Adrenal Disorders for the USMLE, Step One: Abnormalities of the Fasciculata: Hypocortisolism

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

DIMENSIONS 1 cm in diameter 0.5 to 1 gm in weight. LOCATION Sella turcica A bony cavity. DIVISIONS Anterior lobe Posterior lobe Pars intermedia

Transcription:

Pituitary Adenomas: Evaluation and Management Fawn M. Wolf, MD 10/27/17

Over 18,000 pituitaries examined at autopsy: -10.6% contained adenomas (1.5-27%) -Frequency similar for men and women and across all age groups -Vast majority were microadenomas -Approximately half stained for prolactin (22-66%)

Endocrine Evaluation: Functional Adenomas Prolactin. 10-40% of adenomas are prolactinomas YES Acromegaly (growth hormone): IGF-1. 2-10% of adenomas are GH secreting. Cushing s disease (ACTH): cortisol. 1-15% of adenomas are ACTH secreting. Maybe FSH/LH TSH No

Endocrine Evaluation: Hypopituitarism Macroadenomas and larger microadenomas (6-9mm): Common, screening recommended Smaller microadenomas (<6mm): Hypopituitarism rarely occurs Screen only if clinically indicated

Evaluation for Hypopituitarism FSH/LH: common, occurs in 30-70% of patients Pre-menopausal women: menstrual history Post-menopausal women: No HRT: draw FSH, should be elevated HRT: labs unhelpful Men FSH, LH, total +/- free testosterone

Evaluation for Hypopituitarism ACTH: 20-40% Central adrenal insufficiency 8am cortisol or cosyntropin stimulation test GH: 10-50% IGF-1: neither sensitive nor specific. Falsely low: obesity, insulin resistance. Stimulation test: insulin, glucagon TSH 20-40% Overtly low free T4 (or significant drop from known baseline), with inappropriately normal or low TSH PRL: Inability to lactate; overtly low PRL typically only seen following apoplexy

Hyperprolactinemia Clinically apparent prolactinomas: 5-50/100,000 Hypogonadism Prolactin inhibits gonadotropin release Full spectrum of severity Bone loss (trabecular) Galactorrhea

Diagnosis of Prolactinomas Serum draw, any time of day Avoid chest wall stimulation, sexual intercourse, intense exercise for 24 hours prior >250mcg/L: likely a prolactinoma Risperidone, metoclopramide can occasionally cause PRL in the 200s < 250mcg/L: prolactinoma versus non-tumor cause Numerous meds Stalk effect: macroadenomas leading to stalk inhibition as the cause of hyperprolactinemia typically lead to PRLs < 95 mcg/l

When to Consider Cushing s Syndrome Rapid weight gain with proximal weakness Patients with unusual features for age (HTN, osteoporosis) Patients with multiple and progressive features Adrenal adenomas

Diagnosis of Cushing s Syndrome 24h urine free cortisol (UFC)- 2 samples Late night salivary cortisols- 2 samples 1mg overnight dexamethasone suppression test (ONDST) Do not use: 8 am cortisol Imaging prior to biochemical diagnosis

Acromegaly: Clinical Features Soft tissue: hands, feet (ring/shoe size), tongue (macroglossia), nerve impingements (carpal tunnel), pharynx/larynx (sleep apnea in 50-70%) Bone: coarse facial features, enlarged jaw (macronathia), teeth spread apart, dental malocclusions, increase in BMD Skin: skin thickens (difficult venipuncture), skin tags, excessive sweating, hirsutism Joints: hypertrophic arthropathy Viscera: thyroid (goiter +/- nodules)

When to Suspect Acromegaly Combination of DM2, sleep apnea, arthritis/tendonitis, especially if BMI is normal or in the absence of a FH of DM2 New dental malocclusions Heat intolerance, sweating Hand/foot swelling

Acromegaly: Diagnosis Biochemical diagnosis, not a clinical diagnosis Screening IGF-1 Nearly always elevated in patients with acromegaly Few physiologic causes of high IGF-1: puberty and pregnancy Confirmation: 75g oral glucose tolerance. At 2 hours, GH < 1 ng/ml rules out acromegaly.

Additional Work-up Formal visual field (VF) testing for all patients with an incidentaloma abutting the optic nerves or chiasm, even if there are no apparent visual symptoms Pituitary dedicated MRI (fine cuts though the sella w/w/o gadolinium), if initial study was a CT or brain MRI

Indications for Surgery Visual field deficit, ophthalmoplegia or neurological compromise due to the lesion Lesion abutting/compressing optic nerves or chiasm Apoplexy with visual disturbance Functional tumors, other than prolactinomas Consideration of surgery: significant growth over time, hypopituitarism (with resolution in 15-50% of patients), lesions close to the optic chiasm with plans for pregnancy